Monday January 22nd 2018

A Stabilized Release Neuropeptide Exhibits Efficacy in a Phase II Double Blind Placebo Controlled Clinical Trial of Secondary Progressive Multiple…

CONCLUSIONThe medication SR-CRH-01 was well tolerated. Although bladder function in the short DBPC phase was not significantly altered, the trial results implied that longer term administration had a therapeutic effect on bladder instability. The multiple significant secondary outcome results support future development of larger, longer-term studies.Disclosure: Dr. Moore has nothing to disclose. Dr. Vernes has nothing to disclose. Dr. McIntosh has nothing to disclose. Dr. Haq has nothing to disclose. (Source: Neurology)

Continue at source: 

A Stabilized Release Neuropeptide Exhibits Efficacy in a Phase II Double Blind Placebo Controlled Clinical Trial of Secondary Progressive Multiple…

Leave a Comment

More from category

Government Shutdown’s Impact on People with MS
Government Shutdown’s Impact on People with MS

/About-the-Society/News/Government-Shutdown-s-Impact-on-People-with-MS [Read More]

Researchers unravel key molecular mechanism of autoimmune and inflammatory diseases
Researchers unravel key molecular mechanism of autoimmune and inflammatory diseases

An international team of researchers led by prof. Savvas Savvides has unraveled a crucial aspect of the molecular basis [Read More]

Kessler Foundation wins $735,000 grant for training rehabilitation researchers
Kessler Foundation wins $735,000 grant for training rehabilitation researchers

Guang Yue, PhD, director of Human Performance and Engineering Research at Kessler Foundation, has been awarded a [Read More]

6,000-year-old track record for healing leaky gut
6,000-year-old track record for healing leaky gut

When I was traveling in India, I had the privilege of studying Ayurvedic medicine with traditional Master Healers. [Read More]

Study shows high-salt diet causes dementia in mice
Study shows high-salt diet causes dementia in mice

A high-salt diet reduces resting blood flow to the brain and causes dementia in mice, according to a new study by [Read More]